hospital stay.
Susceptibility testing was performed by an agar dilution method according to the CLSI guidelines (2012) [3] . C. freundii CF0638 exhibited high-level resistance to most β-lactam antibiotics tested. The minimum inhibitory concentrations (MICs) of imipenem and meropenem were 4 mg/L and 1 mg/L, respectively (Table 1) . Positive results of the modified Hodge test with meropenem disc and double-disc synergy test between carbapenems and EDTA indicated the production of an MBL. CF0638 was subjected to PCR analysis using the respective primer pairs and amplifying conditions for blaIMP and blaVIM, as described previously [4] , and followed by DNA sequencing. Nucleotide sequence analysis and homology searches were carried out using the BLAST database (http://www.ncbi.nlm.nih.gov). To determine whether the imipenem resistance was transferable, conjugation experiments were carried out in Luria-Bertani (LB) broth with sodium azide-resistant Escherichia coli J53 as the recipient. Transconjugants were selected on LB agar plates supplemented with sodium azide (100 mg/L) and cefotaxime (4 mg/L).
PCR amplification and nucleotide sequence analysis showed that CF0638 harbored blaVIM-4. Conjugation experiments showed that imipenem resistance was successfully transferred to the recipient E. coli J53. PCR analysis of the transconjugant strain was positive for the blaVIM-4 gene. Susceptibility test results of C. freundii CF0638 and its transconjugant are presented in Table 1. C. freundii has been recognized as an opportunistic pathogen that is rarely involved in nosocomial infections. In neonates and www.annlabmed.org immunocompromised patients, however, invasive infections such as bacteremia, meningitis, brain abscesses, pneumonia, endocarditis, and intra-abdominal sepsis have also been reported [5] . VIM-4 is a single amino-acid variant of VIM-1 β-lactamase. VIM-4 was first described in Pseudomonas aeruginosa in Greece [6] , but was subsequently identified as the most common integronencoded MBL in Enterobacteriaceae species in several European countries. C. freundii isolates are usually susceptible to carbapenems and only a limited number of carbapenem-resistant strains have been identified. Prompt and accurate detection of MBL-producing C. freundii strains is necessary to prevent the dissemination of resistance vectors to more virulent pathogens. E. coli J53 < 0.5 < 0.5 < 0.5 < 0.25 < 0.5 < 0.5 < 0.25 < 0.25 < 0.06 < 0.125 < 0.125 < 0.25 < 0.25
Abbreviations: MIC, minimum inhibitory concentration; PIP, piperacillin; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; FOX, cefoxitin; ATM, aztreonam; IMP, imipenem; MEM, meropenem; CIP, ciprofloxacin; LVX, levofloxacin; GAT, gatifloxacin; GM, gentamicin; AMK, amikacin.
